Instauration et optimisation d’une insulinothérapie dans le diabète de type 2 (DT2) en médecine générale : résultats d’une étude observationnelle nationale belge (Etude «InsuStar » réalisée grâce au soutien de Sanofi).
; ; SCHEEN, André
Poster (2015, April)Detailed reference viewed: 44 (4 ULg)
Cardiovascular risk factors and complications associated with impaired renal function and albuminuria in insulin-treated type 2 diabetes
; SCHEEN, André ; et al
in Diabetologia (2011)Detailed reference viewed: 8 (0 ULg)
Poor glycaemic control in secondary care insulin treated patients correlates with bad process indicators
; ; et al
in Diabetologia (2010), 53(s407), 1018Detailed reference viewed: 14 (0 ULg)
Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.
Debacker, Nathalie ; ; et al
in Diabetic Medicine : A Journal of the British Diabetic Association (2008), 25(2), 179-85
AIMS: To describe the IQED, a quality-assurance system started in 2001 in Belgian hospital-based multidisciplinary diabetes centres, and its effects on the quality of care. METHODS: The study was ... [more ▼]
AIMS: To describe the IQED, a quality-assurance system started in 2001 in Belgian hospital-based multidisciplinary diabetes centres, and its effects on the quality of care. METHODS: The study was conducted through four data collections (in 2001, 2002, 2004 and 2006). Approximately 120 diabetes centres provided data on a systematic random sample of 10% of their adult diabetic patients on at least two daily insulin injections. Data on patient characteristics, glycaemic control, cardiovascular risk, diabetes complications, follow-up procedures and treatment were obtained. Local quality promotion was encouraged by returning comprehensive feedback (benchmarks) and during information meetings. RESULTS: Nearly all diabetes centres (98-100%) participated. The pooled sample consisted of 9194 (32%) Type 1 and 19 828 (68%) Type 2 diabetes patients, with mean diabetes duration of 17 years and 14 years, prevalence of microvascular complications of 23% and 38% and prevalence of macrovascular complications of 9% and 26%, respectively. At the start, the quality of care was good in terms of risk-factor testing rates and moderate in terms of patients meeting goals for risk-factor management. At least 50% of the centres initiated quality-promoting initiatives. After 5 years, significant improvements were seen in risk-factor testing rates, apart from renal screening. Improvements in intermediate outcomes were less obvious, apart from an increase in patients reaching the targets for blood pressure and LDL cholesterol. CONCLUSIONS: It is feasible to implement a continuous quality-improvement project on a nationwide scale, with improvements particularly in process indicators. [less ▲]Detailed reference viewed: 40 (2 ULg)
Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients.
; ; et al
in Clinical Genetics (2006), 70(4), 355-9Detailed reference viewed: 16 (1 ULg)
Le role des centres de convention du diabete en Belgique.
; Scheen, André
in Revue Médicale de Liège (2005), 60(5-6), 619-23
We briefly present the modes of functioning of Diabetes Convention Centres in Belgium. In those hospital centres, patients with both type 1 or type 2 diabetes, treated by at least two insulin injections ... [more ▼]
We briefly present the modes of functioning of Diabetes Convention Centres in Belgium. In those hospital centres, patients with both type 1 or type 2 diabetes, treated by at least two insulin injections per day, benefit of an intensive educational programme by a multidisciplinary team and receive free of charge material for home blood glucose monitoring, in order to optimize diabetes management. The collaboration between convention centres and general practitioners should be reinforced (share-care), especially to improve the management of type 2 diabetic patients, who are increasingly treated with various insulin regimens. [less ▲]Detailed reference viewed: 212 (2 ULg)
L'initiative pour la promotion de la qualite et epidemiologie du diabete sucre (IPQED).
; Debacker, Nathalie ; Scheen, André
in Revue Médicale de Liège (2005), 60(5-6), 624-7
Since 2001, the "Diabetes Convention Centres" in Belgium participated to a survey, called IPQED ("Initiative for the Promotion of Quality and Epidemiology of Diabetes mellitus), every 12-18 months. This ... [more ▼]
Since 2001, the "Diabetes Convention Centres" in Belgium participated to a survey, called IPQED ("Initiative for the Promotion of Quality and Epidemiology of Diabetes mellitus), every 12-18 months. This project aims at systematically and anonymously collecting a limited but significant set of data (anamnesis, clinical examination, clinical chemistry: according to DiabCare) in a large sample (about 10%) of type 1 or type 2 diabetic patients followed in the Diabetes Convention Centres (inclusion criteria: at least two injections of insulin per day). IPQED has three main objectives: 1) to optimise the quality of care using a benchmarking process and the creation of quality circles; 2) to provide to health authorities some general advise concerning care for diabetic patients, in general, and in the Convention Diabetes Centres, in particular; and 3) to collect Belgian data among a large cohort of diabetic patients (around 8.000 per survey) that could be used for epidemiological studies. [less ▲]Detailed reference viewed: 188 (6 ULg)
Cabergoline, a new long-acting dopamine agonist, in the treatment of acromegaly
; ; et al
in 10th international Congress of Endocrinology - Abstract book (1996)Detailed reference viewed: 8 (0 ULg)
Hyperfunctioning unilateral adrenal macronodule in three patients with Cushing's disease: hormonal and imaging characterization.
; ; et al
in Acta Endocrinologica (1993), 129(4), 284-90
We aimed to investigate the dynamics of adrenocorticotropin (ACTH) and cortisol secretion in pituitary-dependent Cushing's syndrome with bilateral macronodular adrenal hyperplasia presenting as a single ... [more ▼]
We aimed to investigate the dynamics of adrenocorticotropin (ACTH) and cortisol secretion in pituitary-dependent Cushing's syndrome with bilateral macronodular adrenal hyperplasia presenting as a single adrenal macronodule, and to determine the imaging characteristics of this syndrome. Three female patients were studied. Plasma ACTH and serum cortisol secretion were studied by determining their rhythmicity and pulsatility and their responses to the administration of ovine corticotropin-releasing factor, thyrotropin-releasing hormone, metyrapone, tetracosactrin, insulin and dexamethasone. Techniques used to localize the anatomical lesion were bilateral simultaneous inferior petrosal sinus sampling, magnetic resonance examination of the pituitary, computed tomography (CT) scanning and [75Se]cholesterol scintigraphy of the adrenal glands. Plasma ACTH and serum cortisol levels were measured using a commercial radioimmunoassay and an immunoradiometric assay. The ACTH and cortisol pulse number and amplitude were calculated using established computer software. In all three patients ACTH and cortisol secretory dynamics fulfilled the requirements for diagnosis of pituitary-dependent Cushing's syndrome. A close relationship between ACTH and cortisol pulses also favored a pituitary dependency. Study of the amplitude of cortisol pulses classified two patients in the group of hypopulsatile Cushing's disease. Adrenal CT scanning demonstrated the presence of a large single nodule. [75Se]Cholesterol scintigraphy showed bilateral radionuclide uptake, although mostly localized over the adrenal nodule. All patients underwent successful trans-sphenoidal hypophysectomy. Over a period of 1 year, a slow shrinkage of the adrenal nodule was observed in two patients, while no change in volume was observed in one patient.(ABSTRACT TRUNCATED AT 250 WORDS) [less ▲]Detailed reference viewed: 22 (0 ULg)
ACTH-Related peptide-secreting silent corticotroph adenomas of the pituitary
; ; et al
in Journal of Endocrinological Investigation (1993), 16Detailed reference viewed: 5 (0 ULg)
Hyperfunctioning unilateral adrenal macro-nodule in two patients with cushing's disease : hormonal and imaging characteristics.
; ; et al
Conference (1992)Detailed reference viewed: 9 (0 ULg)
Coexistence of Cushing's disease with uninodular adrenal hyperplasia.
; ; Beckers, Albert
in Journal of Endocrinological Investigation (1991)Detailed reference viewed: 6 (1 ULg)